nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—ORM1—Vismodegib—skin cancer	0.342	0.409	CbGbCtD
Disopyramide—ORM1—Vemurafenib—skin cancer	0.27	0.324	CbGbCtD
Disopyramide—CYP3A4—Imiquimod—skin cancer	0.065	0.0779	CbGbCtD
Disopyramide—CYP3A4—Temozolomide—skin cancer	0.065	0.0779	CbGbCtD
Disopyramide—CYP3A4—Vismodegib—skin cancer	0.045	0.054	CbGbCtD
Disopyramide—CYP3A4—Vemurafenib—skin cancer	0.0356	0.0427	CbGbCtD
Disopyramide—CYP3A4—Docetaxel—skin cancer	0.0122	0.0146	CbGbCtD
Disopyramide—Haemoglobin decreased—Imiquimod—skin cancer	0.00292	0.0176	CcSEcCtD
Disopyramide—Feeling hot—Imiquimod—skin cancer	0.00256	0.0155	CcSEcCtD
Disopyramide—Abdominal pain upper—Vismodegib—skin cancer	0.00253	0.0153	CcSEcCtD
Disopyramide—Hypokalaemia—Vismodegib—skin cancer	0.00252	0.0152	CcSEcCtD
Disopyramide—Tingling sensation—Imiquimod—skin cancer	0.0025	0.0151	CcSEcCtD
Disopyramide—Lupus erythematosus—Docetaxel—skin cancer	0.00215	0.013	CcSEcCtD
Disopyramide—Hypercholesterolaemia—Imiquimod—skin cancer	0.00212	0.0128	CcSEcCtD
Disopyramide—Hepatic enzyme increased—Imiquimod—skin cancer	0.00212	0.0128	CcSEcCtD
Disopyramide—Rash generalised—Docetaxel—skin cancer	0.00188	0.0114	CcSEcCtD
Disopyramide—Dysgeusia—Vismodegib—skin cancer	0.00163	0.00986	CcSEcCtD
Disopyramide—Cardiac failure—Imiquimod—skin cancer	0.00149	0.00902	CcSEcCtD
Disopyramide—Systemic lupus erythematosus—Docetaxel—skin cancer	0.00145	0.00873	CcSEcCtD
Disopyramide—Urinary retention—Imiquimod—skin cancer	0.00139	0.00837	CcSEcCtD
Disopyramide—Tingling sensation—Fluorouracil—skin cancer	0.00138	0.00833	CcSEcCtD
Disopyramide—Numbness—Fluorouracil—skin cancer	0.00134	0.00808	CcSEcCtD
Disopyramide—Skin disorder—Vismodegib—skin cancer	0.00132	0.00798	CcSEcCtD
Disopyramide—Sensory loss—Fluorouracil—skin cancer	0.00128	0.00773	CcSEcCtD
Disopyramide—Hepatic enzyme increased—Temozolomide—skin cancer	0.00127	0.00769	CcSEcCtD
Disopyramide—Sweating increased—Imiquimod—skin cancer	0.00123	0.00742	CcSEcCtD
Disopyramide—Dyspepsia—Vismodegib—skin cancer	0.0012	0.00723	CcSEcCtD
Disopyramide—Decreased appetite—Vismodegib—skin cancer	0.00118	0.00714	CcSEcCtD
Disopyramide—Dysuria—Imiquimod—skin cancer	0.00118	0.00712	CcSEcCtD
Disopyramide—Fatigue—Vismodegib—skin cancer	0.00117	0.00708	CcSEcCtD
Disopyramide—Haemoglobin decreased—Docetaxel—skin cancer	0.00116	0.00703	CcSEcCtD
Disopyramide—Pain—Vismodegib—skin cancer	0.00116	0.00703	CcSEcCtD
Disopyramide—Constipation—Vismodegib—skin cancer	0.00116	0.00703	CcSEcCtD
Disopyramide—Erectile dysfunction—Imiquimod—skin cancer	0.00116	0.00701	CcSEcCtD
Disopyramide—Depression—Imiquimod—skin cancer	0.00112	0.00677	CcSEcCtD
Disopyramide—Dry eye—Temozolomide—skin cancer	0.00111	0.00672	CcSEcCtD
Disopyramide—Coma—Fluorouracil—skin cancer	0.00101	0.00612	CcSEcCtD
Disopyramide—Dysgeusia—Vemurafenib—skin cancer	0.00101	0.00609	CcSEcCtD
Disopyramide—Asthenia—Vismodegib—skin cancer	0.000976	0.00589	CcSEcCtD
Disopyramide—Pruritus—Vismodegib—skin cancer	0.000962	0.00581	CcSEcCtD
Disopyramide—Diarrhoea—Vismodegib—skin cancer	0.000931	0.00562	CcSEcCtD
Disopyramide—Arrhythmia—Imiquimod—skin cancer	0.000901	0.00544	CcSEcCtD
Disopyramide—Diplopia—Temozolomide—skin cancer	0.000874	0.00528	CcSEcCtD
Disopyramide—Vomiting—Vismodegib—skin cancer	0.000865	0.00522	CcSEcCtD
Disopyramide—Rash—Vismodegib—skin cancer	0.000858	0.00518	CcSEcCtD
Disopyramide—Dermatitis—Vismodegib—skin cancer	0.000857	0.00518	CcSEcCtD
Disopyramide—Cardiac failure—Fluorouracil—skin cancer	0.000825	0.00498	CcSEcCtD
Disopyramide—Skin disorder—Vemurafenib—skin cancer	0.000816	0.00493	CcSEcCtD
Disopyramide—Ill-defined disorder—Imiquimod—skin cancer	0.000815	0.00492	CcSEcCtD
Disopyramide—Nausea—Vismodegib—skin cancer	0.000808	0.00488	CcSEcCtD
Disopyramide—Angioedema—Imiquimod—skin cancer	0.000802	0.00485	CcSEcCtD
Disopyramide—Hypokalaemia—Temozolomide—skin cancer	0.000795	0.0048	CcSEcCtD
Disopyramide—Malaise—Imiquimod—skin cancer	0.000792	0.00478	CcSEcCtD
Disopyramide—Syncope—Imiquimod—skin cancer	0.000787	0.00476	CcSEcCtD
Disopyramide—Hypotension—Vemurafenib—skin cancer	0.000785	0.00474	CcSEcCtD
Disopyramide—Neutropenia—Dactinomycin—skin cancer	0.000781	0.00472	CcSEcCtD
Disopyramide—Loss of consciousness—Imiquimod—skin cancer	0.000772	0.00466	CcSEcCtD
Disopyramide—Muscular weakness—Temozolomide—skin cancer	0.000771	0.00466	CcSEcCtD
Disopyramide—Cardiac arrest—Fluorouracil—skin cancer	0.000765	0.00462	CcSEcCtD
Disopyramide—Abdominal distension—Temozolomide—skin cancer	0.00076	0.00459	CcSEcCtD
Disopyramide—Chest pain—Imiquimod—skin cancer	0.000747	0.00452	CcSEcCtD
Disopyramide—Discomfort—Imiquimod—skin cancer	0.000739	0.00446	CcSEcCtD
Disopyramide—Sweating increased—Temozolomide—skin cancer	0.000736	0.00444	CcSEcCtD
Disopyramide—Dry mouth—Imiquimod—skin cancer	0.000731	0.00442	CcSEcCtD
Disopyramide—Decreased appetite—Vemurafenib—skin cancer	0.00073	0.00441	CcSEcCtD
Disopyramide—Fatigue—Vemurafenib—skin cancer	0.000724	0.00438	CcSEcCtD
Disopyramide—Constipation—Vemurafenib—skin cancer	0.000719	0.00434	CcSEcCtD
Disopyramide—Oedema—Imiquimod—skin cancer	0.000717	0.00433	CcSEcCtD
Disopyramide—Hypoaesthesia—Bleomycin—skin cancer	0.000713	0.00431	CcSEcCtD
Disopyramide—Muscular weakness—Fluorouracil—skin cancer	0.00071	0.00429	CcSEcCtD
Disopyramide—Dysuria—Temozolomide—skin cancer	0.000706	0.00427	CcSEcCtD
Disopyramide—Neutropenia—Temozolomide—skin cancer	0.000706	0.00427	CcSEcCtD
Disopyramide—Shock—Imiquimod—skin cancer	0.000705	0.00426	CcSEcCtD
Disopyramide—Pollakiuria—Temozolomide—skin cancer	0.000698	0.00421	CcSEcCtD
Disopyramide—Skin disorder—Imiquimod—skin cancer	0.000696	0.0042	CcSEcCtD
Disopyramide—Erectile dysfunction—Temozolomide—skin cancer	0.000695	0.0042	CcSEcCtD
Disopyramide—Agranulocytosis—Dactinomycin—skin cancer	0.000695	0.0042	CcSEcCtD
Disopyramide—Hyperhidrosis—Imiquimod—skin cancer	0.000693	0.00418	CcSEcCtD
Disopyramide—Weight increased—Temozolomide—skin cancer	0.000687	0.00415	CcSEcCtD
Disopyramide—Anorexia—Imiquimod—skin cancer	0.000683	0.00413	CcSEcCtD
Disopyramide—Depression—Temozolomide—skin cancer	0.000671	0.00406	CcSEcCtD
Disopyramide—Hepatitis—Dactinomycin—skin cancer	0.000668	0.00404	CcSEcCtD
Disopyramide—Body temperature increased—Vemurafenib—skin cancer	0.000664	0.00401	CcSEcCtD
Disopyramide—Insomnia—Imiquimod—skin cancer	0.000648	0.00392	CcSEcCtD
Disopyramide—Paraesthesia—Imiquimod—skin cancer	0.000643	0.00389	CcSEcCtD
Disopyramide—Cardiac failure congestive—Docetaxel—skin cancer	0.000641	0.00387	CcSEcCtD
Disopyramide—Dyspnoea—Imiquimod—skin cancer	0.000639	0.00386	CcSEcCtD
Disopyramide—Somnolence—Imiquimod—skin cancer	0.000637	0.00385	CcSEcCtD
Disopyramide—Dyspepsia—Imiquimod—skin cancer	0.000631	0.00381	CcSEcCtD
Disopyramide—Decreased appetite—Imiquimod—skin cancer	0.000623	0.00376	CcSEcCtD
Disopyramide—Fatigue—Imiquimod—skin cancer	0.000618	0.00373	CcSEcCtD
Disopyramide—Pain—Imiquimod—skin cancer	0.000613	0.0037	CcSEcCtD
Disopyramide—Hepatitis—Temozolomide—skin cancer	0.000604	0.00365	CcSEcCtD
Disopyramide—Asthenia—Vemurafenib—skin cancer	0.000603	0.00364	CcSEcCtD
Disopyramide—Hypoaesthesia—Temozolomide—skin cancer	0.000601	0.00363	CcSEcCtD
Disopyramide—Cardiac failure—Docetaxel—skin cancer	0.000595	0.0036	CcSEcCtD
Disopyramide—Pruritus—Vemurafenib—skin cancer	0.000594	0.00359	CcSEcCtD
Disopyramide—Feeling abnormal—Imiquimod—skin cancer	0.00059	0.00357	CcSEcCtD
Disopyramide—Agranulocytosis—Fluorouracil—skin cancer	0.000579	0.0035	CcSEcCtD
Disopyramide—Ill-defined disorder—Bleomycin—skin cancer	0.000579	0.0035	CcSEcCtD
Disopyramide—Diarrhoea—Vemurafenib—skin cancer	0.000575	0.00347	CcSEcCtD
Disopyramide—Urticaria—Imiquimod—skin cancer	0.000569	0.00344	CcSEcCtD
Disopyramide—Body temperature increased—Imiquimod—skin cancer	0.000566	0.00342	CcSEcCtD
Disopyramide—Malaise—Bleomycin—skin cancer	0.000562	0.0034	CcSEcCtD
Disopyramide—Dizziness—Vemurafenib—skin cancer	0.000556	0.00336	CcSEcCtD
Disopyramide—Hypoaesthesia—Fluorouracil—skin cancer	0.000554	0.00335	CcSEcCtD
Disopyramide—Ill-defined disorder—Dactinomycin—skin cancer	0.00054	0.00326	CcSEcCtD
Disopyramide—Vomiting—Vemurafenib—skin cancer	0.000534	0.00323	CcSEcCtD
Disopyramide—Chest pain—Bleomycin—skin cancer	0.000531	0.00321	CcSEcCtD
Disopyramide—Abdominal pain upper—Docetaxel—skin cancer	0.000531	0.00321	CcSEcCtD
Disopyramide—Rash—Vemurafenib—skin cancer	0.00053	0.0032	CcSEcCtD
Disopyramide—Dermatitis—Vemurafenib—skin cancer	0.000529	0.0032	CcSEcCtD
Disopyramide—Headache—Vemurafenib—skin cancer	0.000526	0.00318	CcSEcCtD
Disopyramide—Discomfort—Bleomycin—skin cancer	0.000525	0.00317	CcSEcCtD
Disopyramide—Malaise—Dactinomycin—skin cancer	0.000525	0.00317	CcSEcCtD
Disopyramide—Dysgeusia—Temozolomide—skin cancer	0.000515	0.00311	CcSEcCtD
Disopyramide—Asthenia—Imiquimod—skin cancer	0.000514	0.00311	CcSEcCtD
Disopyramide—Confusional state—Bleomycin—skin cancer	0.000513	0.0031	CcSEcCtD
Disopyramide—Oedema—Bleomycin—skin cancer	0.000509	0.00308	CcSEcCtD
Disopyramide—Pruritus—Imiquimod—skin cancer	0.000507	0.00306	CcSEcCtD
Disopyramide—Nausea—Vemurafenib—skin cancer	0.000499	0.00302	CcSEcCtD
Disopyramide—Thrombocytopenia—Bleomycin—skin cancer	0.000498	0.00301	CcSEcCtD
Disopyramide—Arrhythmia—Fluorouracil—skin cancer	0.000497	0.00301	CcSEcCtD
Disopyramide—Vision blurred—Temozolomide—skin cancer	0.000496	0.003	CcSEcCtD
Disopyramide—Diarrhoea—Imiquimod—skin cancer	0.00049	0.00296	CcSEcCtD
Disopyramide—Discomfort—Dactinomycin—skin cancer	0.000489	0.00296	CcSEcCtD
Disopyramide—Ill-defined disorder—Temozolomide—skin cancer	0.000488	0.00295	CcSEcCtD
Disopyramide—Anorexia—Bleomycin—skin cancer	0.000485	0.00293	CcSEcCtD
Disopyramide—Angioedema—Temozolomide—skin cancer	0.000481	0.0029	CcSEcCtD
Disopyramide—Hypotension—Bleomycin—skin cancer	0.000476	0.00287	CcSEcCtD
Disopyramide—Oedema—Dactinomycin—skin cancer	0.000475	0.00287	CcSEcCtD
Disopyramide—Malaise—Temozolomide—skin cancer	0.000474	0.00287	CcSEcCtD
Disopyramide—Dizziness—Imiquimod—skin cancer	0.000474	0.00286	CcSEcCtD
Disopyramide—Vertigo—Temozolomide—skin cancer	0.000473	0.00286	CcSEcCtD
Disopyramide—Neutropenia—Docetaxel—skin cancer	0.00047	0.00284	CcSEcCtD
Disopyramide—Thrombocytopenia—Dactinomycin—skin cancer	0.000465	0.00281	CcSEcCtD
Disopyramide—Paraesthesia—Bleomycin—skin cancer	0.000457	0.00276	CcSEcCtD
Disopyramide—Weight increased—Docetaxel—skin cancer	0.000457	0.00276	CcSEcCtD
Disopyramide—Vision blurred—Fluorouracil—skin cancer	0.000457	0.00276	CcSEcCtD
Disopyramide—Vomiting—Imiquimod—skin cancer	0.000456	0.00275	CcSEcCtD
Disopyramide—Dyspnoea—Bleomycin—skin cancer	0.000454	0.00274	CcSEcCtD
Disopyramide—Anorexia—Dactinomycin—skin cancer	0.000453	0.00273	CcSEcCtD
Disopyramide—Rash—Imiquimod—skin cancer	0.000452	0.00273	CcSEcCtD
Disopyramide—Dermatitis—Imiquimod—skin cancer	0.000451	0.00273	CcSEcCtD
Disopyramide—Headache—Imiquimod—skin cancer	0.000449	0.00271	CcSEcCtD
Disopyramide—Discomfort—Temozolomide—skin cancer	0.000443	0.00267	CcSEcCtD
Disopyramide—Decreased appetite—Bleomycin—skin cancer	0.000443	0.00267	CcSEcCtD
Disopyramide—Dry mouth—Temozolomide—skin cancer	0.000438	0.00265	CcSEcCtD
Disopyramide—Pain—Bleomycin—skin cancer	0.000435	0.00263	CcSEcCtD
Disopyramide—Confusional state—Temozolomide—skin cancer	0.000433	0.00262	CcSEcCtD
Disopyramide—Oedema—Temozolomide—skin cancer	0.000429	0.00259	CcSEcCtD
Disopyramide—Nausea—Imiquimod—skin cancer	0.000426	0.00257	CcSEcCtD
Disopyramide—Thrombocytopenia—Temozolomide—skin cancer	0.00042	0.00254	CcSEcCtD
Disopyramide—Feeling abnormal—Bleomycin—skin cancer	0.000419	0.00253	CcSEcCtD
Disopyramide—Agranulocytosis—Docetaxel—skin cancer	0.000418	0.00252	CcSEcCtD
Disopyramide—Skin disorder—Temozolomide—skin cancer	0.000417	0.00252	CcSEcCtD
Disopyramide—Hyperhidrosis—Temozolomide—skin cancer	0.000415	0.00251	CcSEcCtD
Disopyramide—Chest pain—Fluorouracil—skin cancer	0.000413	0.00249	CcSEcCtD
Disopyramide—Decreased appetite—Dactinomycin—skin cancer	0.000413	0.00249	CcSEcCtD
Disopyramide—Fatigue—Dactinomycin—skin cancer	0.000409	0.00247	CcSEcCtD
Disopyramide—Anorexia—Temozolomide—skin cancer	0.000409	0.00247	CcSEcCtD
Disopyramide—Discomfort—Fluorouracil—skin cancer	0.000408	0.00246	CcSEcCtD
Disopyramide—Pain—Dactinomycin—skin cancer	0.000406	0.00245	CcSEcCtD
Disopyramide—Urticaria—Bleomycin—skin cancer	0.000404	0.00244	CcSEcCtD
Disopyramide—Body temperature increased—Bleomycin—skin cancer	0.000402	0.00243	CcSEcCtD
Disopyramide—Hepatitis—Docetaxel—skin cancer	0.000402	0.00243	CcSEcCtD
Disopyramide—Hypoaesthesia—Docetaxel—skin cancer	0.0004	0.00242	CcSEcCtD
Disopyramide—Confusional state—Fluorouracil—skin cancer	0.000399	0.00241	CcSEcCtD
Disopyramide—Oedema—Fluorouracil—skin cancer	0.000396	0.00239	CcSEcCtD
Disopyramide—Feeling abnormal—Dactinomycin—skin cancer	0.000391	0.00236	CcSEcCtD
Disopyramide—Insomnia—Temozolomide—skin cancer	0.000388	0.00235	CcSEcCtD
Disopyramide—Thrombocytopenia—Fluorouracil—skin cancer	0.000387	0.00234	CcSEcCtD
Disopyramide—Paraesthesia—Temozolomide—skin cancer	0.000386	0.00233	CcSEcCtD
Disopyramide—Dyspnoea—Temozolomide—skin cancer	0.000383	0.00231	CcSEcCtD
Disopyramide—Somnolence—Temozolomide—skin cancer	0.000382	0.00231	CcSEcCtD
Disopyramide—Dyspepsia—Temozolomide—skin cancer	0.000378	0.00228	CcSEcCtD
Disopyramide—Anorexia—Fluorouracil—skin cancer	0.000377	0.00228	CcSEcCtD
Disopyramide—Body temperature increased—Dactinomycin—skin cancer	0.000375	0.00227	CcSEcCtD
Disopyramide—Decreased appetite—Temozolomide—skin cancer	0.000373	0.00226	CcSEcCtD
Disopyramide—Fatigue—Temozolomide—skin cancer	0.00037	0.00224	CcSEcCtD
Disopyramide—Hypotension—Fluorouracil—skin cancer	0.00037	0.00223	CcSEcCtD
Disopyramide—Pain—Temozolomide—skin cancer	0.000367	0.00222	CcSEcCtD
Disopyramide—Constipation—Temozolomide—skin cancer	0.000367	0.00222	CcSEcCtD
Disopyramide—Asthenia—Bleomycin—skin cancer	0.000365	0.00221	CcSEcCtD
Disopyramide—Pruritus—Bleomycin—skin cancer	0.00036	0.00218	CcSEcCtD
Disopyramide—Arrhythmia—Docetaxel—skin cancer	0.000359	0.00217	CcSEcCtD
Disopyramide—Insomnia—Fluorouracil—skin cancer	0.000358	0.00216	CcSEcCtD
Disopyramide—Paraesthesia—Fluorouracil—skin cancer	0.000355	0.00215	CcSEcCtD
Disopyramide—Feeling abnormal—Temozolomide—skin cancer	0.000354	0.00214	CcSEcCtD
Disopyramide—Dyspnoea—Fluorouracil—skin cancer	0.000353	0.00213	CcSEcCtD
Disopyramide—Somnolence—Fluorouracil—skin cancer	0.000352	0.00212	CcSEcCtD
Disopyramide—Dyspepsia—Fluorouracil—skin cancer	0.000348	0.0021	CcSEcCtD
Disopyramide—Decreased appetite—Fluorouracil—skin cancer	0.000344	0.00208	CcSEcCtD
Disopyramide—Dysgeusia—Docetaxel—skin cancer	0.000343	0.00207	CcSEcCtD
Disopyramide—Urticaria—Temozolomide—skin cancer	0.000341	0.00206	CcSEcCtD
Disopyramide—Asthenia—Dactinomycin—skin cancer	0.000341	0.00206	CcSEcCtD
Disopyramide—Body temperature increased—Temozolomide—skin cancer	0.000339	0.00205	CcSEcCtD
Disopyramide—Pain—Fluorouracil—skin cancer	0.000338	0.00204	CcSEcCtD
Disopyramide—Feeling abnormal—Fluorouracil—skin cancer	0.000326	0.00197	CcSEcCtD
Disopyramide—Diarrhoea—Dactinomycin—skin cancer	0.000325	0.00196	CcSEcCtD
Disopyramide—Vomiting—Bleomycin—skin cancer	0.000324	0.00196	CcSEcCtD
Disopyramide—Rash—Bleomycin—skin cancer	0.000321	0.00194	CcSEcCtD
Disopyramide—Dermatitis—Bleomycin—skin cancer	0.000321	0.00194	CcSEcCtD
Disopyramide—Urticaria—Fluorouracil—skin cancer	0.000314	0.0019	CcSEcCtD
Disopyramide—Syncope—Docetaxel—skin cancer	0.000314	0.0019	CcSEcCtD
Disopyramide—Body temperature increased—Fluorouracil—skin cancer	0.000313	0.00189	CcSEcCtD
Disopyramide—Asthenia—Temozolomide—skin cancer	0.000308	0.00186	CcSEcCtD
Disopyramide—Loss of consciousness—Docetaxel—skin cancer	0.000308	0.00186	CcSEcCtD
Disopyramide—Pruritus—Temozolomide—skin cancer	0.000304	0.00184	CcSEcCtD
Disopyramide—Nausea—Bleomycin—skin cancer	0.000302	0.00183	CcSEcCtD
Disopyramide—Vomiting—Dactinomycin—skin cancer	0.000302	0.00182	CcSEcCtD
Disopyramide—Rash—Dactinomycin—skin cancer	0.000299	0.00181	CcSEcCtD
Disopyramide—Chest pain—Docetaxel—skin cancer	0.000298	0.0018	CcSEcCtD
Disopyramide—Diarrhoea—Temozolomide—skin cancer	0.000294	0.00177	CcSEcCtD
Disopyramide—Dry mouth—Docetaxel—skin cancer	0.000291	0.00176	CcSEcCtD
Disopyramide—Confusional state—Docetaxel—skin cancer	0.000288	0.00174	CcSEcCtD
Disopyramide—Oedema—Docetaxel—skin cancer	0.000286	0.00173	CcSEcCtD
Disopyramide—Dizziness—Temozolomide—skin cancer	0.000284	0.00172	CcSEcCtD
Disopyramide—Nausea—Dactinomycin—skin cancer	0.000282	0.0017	CcSEcCtD
Disopyramide—Shock—Docetaxel—skin cancer	0.000281	0.0017	CcSEcCtD
Disopyramide—Pruritus—Fluorouracil—skin cancer	0.00028	0.00169	CcSEcCtD
Disopyramide—Thrombocytopenia—Docetaxel—skin cancer	0.00028	0.00169	CcSEcCtD
Disopyramide—Skin disorder—Docetaxel—skin cancer	0.000277	0.00168	CcSEcCtD
Disopyramide—Vomiting—Temozolomide—skin cancer	0.000273	0.00165	CcSEcCtD
Disopyramide—Anorexia—Docetaxel—skin cancer	0.000272	0.00164	CcSEcCtD
Disopyramide—Rash—Temozolomide—skin cancer	0.000271	0.00164	CcSEcCtD
Disopyramide—Diarrhoea—Fluorouracil—skin cancer	0.000271	0.00164	CcSEcCtD
Disopyramide—Dermatitis—Temozolomide—skin cancer	0.00027	0.00163	CcSEcCtD
Disopyramide—Headache—Temozolomide—skin cancer	0.000269	0.00163	CcSEcCtD
Disopyramide—Hypotension—Docetaxel—skin cancer	0.000267	0.00161	CcSEcCtD
Disopyramide—Dizziness—Fluorouracil—skin cancer	0.000262	0.00158	CcSEcCtD
Disopyramide—Insomnia—Docetaxel—skin cancer	0.000258	0.00156	CcSEcCtD
Disopyramide—Paraesthesia—Docetaxel—skin cancer	0.000256	0.00155	CcSEcCtD
Disopyramide—Nausea—Temozolomide—skin cancer	0.000255	0.00154	CcSEcCtD
Disopyramide—Dyspnoea—Docetaxel—skin cancer	0.000255	0.00154	CcSEcCtD
Disopyramide—Somnolence—Docetaxel—skin cancer	0.000254	0.00153	CcSEcCtD
Disopyramide—Vomiting—Fluorouracil—skin cancer	0.000252	0.00152	CcSEcCtD
Disopyramide—Dyspepsia—Docetaxel—skin cancer	0.000251	0.00152	CcSEcCtD
Disopyramide—Rash—Fluorouracil—skin cancer	0.000249	0.00151	CcSEcCtD
Disopyramide—Dermatitis—Fluorouracil—skin cancer	0.000249	0.00151	CcSEcCtD
Disopyramide—Decreased appetite—Docetaxel—skin cancer	0.000248	0.0015	CcSEcCtD
Disopyramide—Headache—Fluorouracil—skin cancer	0.000248	0.0015	CcSEcCtD
Disopyramide—Fatigue—Docetaxel—skin cancer	0.000246	0.00149	CcSEcCtD
Disopyramide—Pain—Docetaxel—skin cancer	0.000244	0.00148	CcSEcCtD
Disopyramide—Constipation—Docetaxel—skin cancer	0.000244	0.00148	CcSEcCtD
Disopyramide—Feeling abnormal—Docetaxel—skin cancer	0.000235	0.00142	CcSEcCtD
Disopyramide—Nausea—Fluorouracil—skin cancer	0.000235	0.00142	CcSEcCtD
Disopyramide—Body temperature increased—Docetaxel—skin cancer	0.000226	0.00136	CcSEcCtD
Disopyramide—Asthenia—Docetaxel—skin cancer	0.000205	0.00124	CcSEcCtD
Disopyramide—Pruritus—Docetaxel—skin cancer	0.000202	0.00122	CcSEcCtD
Disopyramide—Diarrhoea—Docetaxel—skin cancer	0.000195	0.00118	CcSEcCtD
Disopyramide—Dizziness—Docetaxel—skin cancer	0.000189	0.00114	CcSEcCtD
Disopyramide—Vomiting—Docetaxel—skin cancer	0.000182	0.0011	CcSEcCtD
Disopyramide—Rash—Docetaxel—skin cancer	0.00018	0.00109	CcSEcCtD
Disopyramide—Dermatitis—Docetaxel—skin cancer	0.00018	0.00109	CcSEcCtD
Disopyramide—Headache—Docetaxel—skin cancer	0.000179	0.00108	CcSEcCtD
Disopyramide—Nausea—Docetaxel—skin cancer	0.00017	0.00102	CcSEcCtD
